Literature DB >> 12068005

Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.

Cynthia A Pise-Masison1, Michael Radonovich, Renaud Mahieux, Pramita Chatterjee, Craig Whiteford, Janet Duvall, Claire Guillerm, Antoine Gessain, John N Brady.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent for adult T-cell leukemia and the neurological disorder tropical spastic paraparesis/HTLV-I-associated myelopathy. CD4+ T lymphocytes, the primary hosts for HTLV-I, undergo a series of changes that lead to T-cell activation, immortalization, and transformation. To gain insight into the genetic differences between activated and HTLV-I-infected lymphocytes, we performed Affymetrix GeneChip analysis of activated and HTLV-I-infected cells. Using the Hu6800 GeneChip, we identified approximately 763 genes that had differentially regulated expression in at least three of five HTLV-I cell lines. Classification of these genes into functional groups including cellular receptors, kinases, phosphatases, cytokines, signal proteins, and transcription factors provides insight into genes and pathways that are differentially regulated during HTLV-I transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068005

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 2.  HTLV-1 p13, a small protein with a busy agenda.

Authors:  Micol Silic-Benussi; Roberta Biasiotto; Vibeke Andresen; Genoveffa Franchini; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Mol Aspects Med       Date:  2010-03-21

3.  Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.

Authors:  Masaaki Watanabe; Shingo Nakahata; Makoto Hamasaki; Yusuke Saito; Yohei Kawano; Tomonori Hidaka; Kiyoshi Yamashita; Kazumi Umeki; Tomohiko Taki; Masafumi Taniwaki; Akihiko Okayama; Kazuhiro Morishita
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

4.  Paraoxonase 2 serves a proapopotic function in mouse and human cells in response to the Pseudomonas aeruginosa quorum-sensing molecule N-(3-Oxododecanoyl)-homoserine lactone.

Authors:  Christian Schwarzer; Zhu Fu; Takeshi Morita; Aaron G Whitt; Aaron M Neely; Chi Li; Terry E Machen
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

5.  Reverse engineering gene networks using global-local shrinkage rules.

Authors:  Viral Panchal; Daniel F Linder
Journal:  Interface Focus       Date:  2019-12-13       Impact factor: 3.906

6.  Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.

Authors:  Ash A Alizadeh; Sean P Bohen; Chen Lossos; Jose A Martinez-Climent; Juan Carlos Ramos; Elena Cubedo-Gil; William J Harrington; Izidore S Lossos
Journal:  Leuk Lymphoma       Date:  2010-07

Review 7.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Hanxin Lu; Cynthia A Pise-Masison; Rebecca Linton; Hyeon Ung Park; R Louis Schiltz; Vittorio Sartorelli; John N Brady
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression.

Authors:  Dustin C Edwards; Susan J Marriott
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.